Radha Rajasingham

Credentials: · · ·

History

A Randomized Trial to Evaluate the Optimal Timing of Antiretroviral Therapy Initiation in Persons with Early Disseminated Cryptococcal Infection
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $693.5K · University of Minnesota
2026–2031
Mentoring Patient-Oriented Research in the Evaluation of Novel Diagnostics for People With Advanced HIV Disease
National Institute of Allergy and Infectious Diseases · K24
Contact PI · $220.5K · University of Minnesota
2026–2031
Enhanced Antifungal Therapy to Improve Survival in Early Disseminated Cryptococcal Infection
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $2.6M · University of Minnesota
2023–2028
An Enhanced Package of Care to Reduce Mortality in Persons with Advanced HIV Disease
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.2M · University of Minnesota
2021–2027

Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers
Principal investigator · Not yet recruiting · Phase 3
University of Minnesota
2027–2031
Pre-exposure Prophylaxis for SARS-Coronavirus-2
Principal investigator · Completed · Phase 3
University of Minnesota
2020
Cryptococcal Antigen Screening Plus Sertraline
Study director · Terminated · Phase 3
University of Minnesota
2017–2018
Operational Research for Cryptococcal Antigen Screening
Study director · Completed · Phase 4
University of Minnesota
2012–2015